US 9254316
Adenoviral vector-based malaria vaccines
granted A61KA61K2039/53A61K39/015
Quick answer
US patent 9254316 (Adenoviral vector-based malaria vaccines) held by United States of America as represented by the Secretary of the Air Force expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States of America as represented by the Secretary of the Air Force
- Grant date
- Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2039/53, A61K39/015